IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
Go back to IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates| (NASDAQ: ICCM) | Delayed: 5.93 +0.53 (9.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.40 | 52 Week High | $ | |||
| Open | $7.06 | 52 Week Low | $ | |||
| Day High | $7.53 | P/E | N/A | |||
| Day Low | $5.61 | EPS | $ | |||
| Volume | 15,898,920 | |||||

